farampator developmental code names ampakine drug developed cortex pharmaceuticals licensed organon biosciences commercial development following purchase organon scheringplough development license farampator transferred development farampator eventually terminated reportedly due concerns cardiac farampator investigated effect ampa receptors researched potential use treatment schizophrenia alzheimers disease found improve shortterm memory impaired episodic memory produced side effects headache somnolence nausea subjects reporting side effects significantly higher plasma levels farampator subjects withoutcitation needed additional analyses revealed farampator condition group without side effects showed significantly superior memory performance relative group side drug article relating nervous system stub help wikipedia expanding httpsenwikipediaorgwikifarampator